REGENT SQUARE GROUP PRACTICE
8-9 REGENT SQUARE, DONCASTER
HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 32 | 37 | 86.5% | |
| HF 4 | 2011 | 34 | 42 | 81.0% | |
| HF 4 | 2012 | 38 | 43 | 88.4% | |
| HF 4 | 2013 | 45 | 52 | 86.5% | |
| HF004 | 2014 | 41 | 50 | 82.0% | |
| HF004 | 2015 | 42 | 47 | 89.4% | |
| HF004 | 2016 | 38 | 41 | 92.7% | |
| HF004 | 2017 | 38 | 44 | 86.4% | |
| HF004 | 2018 | 35 | 41 | 85.4% | |
| HF004 | 2019 | 31 | 36 | 86.1% | |
| HF004 | 2020 | 29 | 34 | 85.3% | |
| HF006 | 2021 | 36 | 41 | 87.8% | |
| HF006 | 2022 | 37 | 40 | 92.5% | |
| HF006 | 2023 | 35 | 37 | 94.6% |
